This is unexpected, as IRF1 is the main transcription factor driving PD-L1 promoter function in melanoma cells [36], and thus IRF1 knockdown would be anticipated to drastically decrease PD-L1 expression in melanoma cells, irrespective of differentiation state. The gene discussed is IRF1; the disease is melanoma.